...
机译:CD44靶向可编程药物递送系统,用于增强和致敏化疗,对耐药性癌症
China Pharmaceut Univ Sch Engn Dept Biomed Engn State Key Lab Nat Med Jiangsu Key Lab Drug Screen Nanjing 210009 Jiangsu Peoples R China;
China Pharmaceut Univ Sch Engn Dept Biomed Engn State Key Lab Nat Med Jiangsu Key Lab Drug Screen Nanjing 210009 Jiangsu Peoples R China;
China Pharmaceut Univ Sch Engn Dept Biomed Engn State Key Lab Nat Med Jiangsu Key Lab Drug Screen Nanjing 210009 Jiangsu Peoples R China;
China Pharmaceut Univ Sch Engn Dept Biomed Engn State Key Lab Nat Med Jiangsu Key Lab Drug Screen Nanjing 210009 Jiangsu Peoples R China;
China Pharmaceut Univ Sch Engn Dept Biomed Engn State Key Lab Nat Med Jiangsu Key Lab Drug Screen Nanjing 210009 Jiangsu Peoples R China;
China Pharmaceut Univ Sch Engn Dept Biomed Engn State Key Lab Nat Med Jiangsu Key Lab Drug Screen Nanjing 210009 Jiangsu Peoples R China;
China Pharmaceut Univ Sch Engn Dept Biomed Engn State Key Lab Nat Med Jiangsu Key Lab Drug Screen Nanjing 210009 Jiangsu Peoples R China;
Programmable sequential effect; CD44-targeting; Drug-resistant cancer; Sensitized therapy; Chondroitin sulfate;
机译:CD44靶向可编程药物递送系统,用于增强和致敏化疗,对耐药性癌症
机译:等离子纳米气泡增强的内体逃逸过程,可选择性地和指导性地将细胞内化疗递送给耐药性癌细胞
机译:药物递送胶束,具有高效的近红外光敏剂,用于组合图像引导的光动力治疗和耐药性癌症化疗
机译:抗癌药物分子水凝胶作为化学疗法的新型自我传递系统
机译:脂质体组合药物和siRNA递送,用于打击耐药卵巢癌
机译:增强抗毒性癌细胞的选择性和指导细胞内递送的血浆纳米柔臼增强的内骨逸出方法
机译:增强抗毒性癌细胞的选择性和指导细胞内递送的血浆纳米柔臼增强的内骨逸出方法